Dr. Zakaria Gad Chairman and CEO

MUP In Brief

Medical Union Pharmaceuticals company (MUP) is a modern Pharmaceutical manufacturing facility which incorporates many contemporary construction design features, raw materials handling, production flow concepts, air and water processing units and state of art manufacturing equipments which rival the most modern American, European and Japanese counterparts.

MUP from the first day of production adopted the Total Quality Management (TOM) concept and methology in all departments and up-to-date Quality Assurance (QA) techniques, not only in all production processes, but also in all administrative and supporting departments. A status which culminated in acquiring the ISO 9001 Certificate from the British Standards Institute (BSI) in 1996.

MUP strives to meet the needs of its partners in the health care triangle, namely, physicians, pharmacists and patients, through three critical dimensions:

QUALITY, RELIABILITY & CREDIBILITY

MUP has welcomed, along the last decade, teams of inspectors from the American FDA, as well as from the international pharmaceutical manufactures: Schering-Plough (USA), Smith Kline-Beecham (UK), Mepha (Switzerland) and American Cyanamid (USA), whose audit documents testify to the high standards of performance of MUP production processes and QA techniques.

Because the dimension of quality involves measurable attributes, both the MUP-Plant and MUP-Products ranked high by these international teams, on individual aspects of performance and efficiency, compared to many other pharmaceutical manufactures in the region.

Consequently, these international manufacturers have placed so much confidence and trust in MUP so as to rely on the company to produce their top ranking brand names under license.

This, in turn, reflects the complete confidence these companies have had in the Quality, Reliability and Credibility of MUP.

In the span often years MUP offered a wide range of product lines both as its own Specialties and as Licensed Products (in addition to products for Tender and Export) Covering over 30 therapeutic groups.

These include antibiotics, antirheumatics, gastroentrology products, dermatological, multivitamins and tonics, and, the exclusive Baby-Care Line which addresses the vital and long neglected infant age group of patients for whom very few or no adequate products were available on the Egyptian market before the pioneering effort of MUP.

This well-balanced product portfolio of MUP provides the physicians, whether General Practitioners or Specialists in all branches, with wide selection of medicines endowed with top quality, high efficacy and absolute safety.

MUP Company employs a select and elite group of experts with high qualifications in the various disciplines of research, development, planning, production and quality control. Many of the employees have higher degrees beyond the bachelor reaching the master's and Ph.D. degrees. Furthermore in top management and leaders posts, many members have full professorships from Egyptian as well as American Universities. Embers of this strong team have had long experience and intense practice in the field of manufacturing of pharmaceuticals.

As to the junior staff members only the choicest applicants and best elements are selected to fill the posts of pharmacists, chemists, engineers as well as skilled workers. This practice ensures the maximum efficiency and reliability.

MUP has a high-level scientific committee, which includes as its members the top and leading professors in various clinical domains as well as other medical discipline. This committee has an important role in directing the R & D efforts to new horizons in medical treatment.

MUP has the highest rate of growth in sales along the last ten years. The sales in 1990 were 4.5 million and raised up to 220 million in 1999.

The equity, as well, has been raised from 22 million in year 1990 up to 313 million in 1999. The number of products developed through.

MUP laboratories were 19 in 1991 and raised up to 158 in 1999.